Description
Synopsis: This is a request for information. Information from this RFI is not being considered for public verification; the information may support a future procurement for CDC staff. It is not a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to: Obtain information on contractors’ capabilities, processes, technical requirements, and capacity to provide electronic verification of COVID-19 vaccination and testing of CDC staff, including providing verified information for travel (both domestic and international). Make use of this information to inform acquisition strategies that may be used to support workforce vaccination and testing, as well as preparedness and response to public health emergencies requiring travel to locations that require electronically verifiable COVID-19 vaccine and/or test results. Background: The Centers for Disease Control and Prevention (CDC) has a workforce of about 25,000 people globally. Most of these individuals will report to a CDC facility or other facility (e.g., labs, universities, health departments) requiring proof of vaccination or negative COVID-19 test. There are different criteria based on staff type (e.g., federal employee, contractor). In addition, CDC travels staff to foreign and domestic locations to help with public health issues. Global travel requirements relating to COVID-19 are changing and depending on location, some countries are requiring COVID-19 electronic verifiable tests and/or vaccine proof for entry. Some facilities and countries have also adopted policies that require electronic verifiable vaccination proof in order to be exempt from quarantine. Requirement: CDC is seeking to understand contractors’ capabilities to provide electronically verifiable vaccination record and/or electronically verifiable test results for CDC personnel. In addition, CDC would like to understand contractors’ ability to import information on CDC personnel, provided by CDC systems, which drive access requirements. CDC has travelers departing from various locations within the United States. CDC typically travels approximately 5,000 employees to foreign locations each year to a wide variety of locations. Submission Instructions: Respondents are asked to provide only the most pertinent information, data, and materials necessary to adequately convey a declaration of capability in line with this notice. Respondents are asked to provide a cover page that contains the following information: All Point of Contact information (email addresses, phone numbers, and mailing address) DUNS number All relevant NAICS Codes Identification as a large or small business. If small, indicate the classification. Identification of services on any Federal Supply Schedules, if any, and the relevant schedule numbers. Respondents are asked to provide the following information: Product/service literature and specifications sheets for providing electronic verifiable test and vaccine proof services (attach as an electronic pdf or Microsoft Word documents). Specifically describe the logistical and practical methods for receipt, storage, and communication of data from CDC and partner systems (e.g., CDC occupational health medical records, 3rd partner COVID-19 testing lab, CDC access control). Specifically describe the logistical and practical methods for receipt, storage, and communication of data supporting electronically verifiable proof of COVID-19 test and/or vaccination from 3rd party providers (e.g., national pharmacy chains providing testing and vaccination, state immunization information systems, health systems providing authenticated data) related to CDC personnel. Specifically address what geographical locations/countries have accepted your means of electronically verifiable proof of COVID-19 test and/or vaccination. Specifically indicate whether your company will accept a Government Travel Card (credit card) as a form of payment. General information on the company’s line of products and market capabilities (attach as an electronic pdf or Microsoft Word document). Information on the company’s process and supplies required to: Provide/display electronic verifiable COVID-19 test results. Provide/display electronic verifiable COVID-19 vaccine record. Proprietary information, if any, should be minimized and MUST BE CLEARLY MARKED. To aid CDC, please segregate and clearly mark proprietary information. Please be advised that all submissions become the property of the Government and will not be returned. This REQUEST FOR INFORMATION is in accordance with FAR 52.215-3 Request for Information or Solicitation for Planning Purposes (Oct 1997), as such, any information received will be for the purpose of planning only. Responses to this REQUEST FOR INFORMATION notice, along with a firm’s capability statement referencing “Request for Information – Verifiable Test and Vaccine Proof” may be submitted electronically via email to the points of contact identified in this notice NO LATER THAN 10/5/2021 4PM EST,.